Stable Gene-Silence of Kif2a Synergistic with 5-Fluorouracil Suppresses Oral Tongue Squamous Cell Carcinoma Growth in Vitro and in Vivo

Cheng-Qin Wang,Yu-Jun Li,Zhi-Min Wei,Chang-Jun Zhu,Xun Qu,Feng-Cai Wei,Xiao-Ming Xing,Wen-Juan Yu
DOI: https://doi.org/10.1016/j.oooo.2013.01.028
2013-01-01
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Abstract:OBJECTIVE:Squamous cell carcinoma of the oral tongue (SCCOT) is one of the most common malignant carcinomas in the head and neck. Recurrence and/or metastasis often results in failure of treatment and decreases the survival of the patients. The purpose of this study is to investigate the effect of gene-silence of Kif2a on SCCOT in viro and in vivo.STUDY DESIGN:Plasmid-mediated expression of Kif2a-siRNA (pGPU6/GFP/Kif2a) was employed to silence the expression of Kif2a in Tca8113 cells at both mRNA and protein levels. Tca8113 cell proliferation was measured by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay and growth of Tca8113 tumors was determined by intra-tumor injection of pGPU6/GFP/Kif2a in nude mice.RESULTS:Gene-silence of Kif2a suppressed Tca8113 cell proliferation. pGPU6/GFP/Kif2a synergized the tumor suppression effect of 5-Fluorouracil (5-Fu) on Tca8113 cells.CONCLUSIONS:Our data support that Kif2a is a potential molecular target for the therapeutics of recurrent and metastatic SCCOT.
What problem does this paper attempt to address?